On May 24, 2010, James S. Cohen — a shareholder in the Food and Drug Section of Buchanan Ingersoll & Rooney's Washington, D.C., office — moderated and delivered an opening day panel presentation at the American Conference Institute's FDA Enforcement Summit, which was attended principally by members of general counsel office's of pharmaceutical and other FDA-regulated companies. Cohen's panel, "Inspection Spotlight," focused on inspection-related developments, trends and insights in the new era of FDA enforcement.